KROS Archived Articles
Keros Therapeutics (KROS): A Clinical-Stage Biotech Navigating Challenges, Poised for Potential Breakthroughs
Published on March 14, 2025
Keros Therapeutics, Inc. (KROS): Pioneering TGF-β Targeted Therapies for Complex Disorders
Published on November 30, 2024
Keros Therapeutics, Inc. (NASDAQ:KROS): A Promising Biopharmaceutical Company Advancing Novel Therapies
Published on September 24, 2024